Amaia Cadinanos-Garai

Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

M. Abbasian, K. Peggs, F. Farzaneh, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Non-viral chimeric antigen receptor (CAR) T cells going viral

Annie Brown, H. Balke-Want, Ramya H. Tunuguntla, 2023, Immuno-oncology technology.